tirzepatide clinical trial New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Tirzepatide cardiovascular event risk assessment:

So you will often drink less water, which makes you dehydrated

The American College of Physicians emphasizes shared decision-making in obesity management, making open communication about treatment experience, including hunger, an essential component of successful outcomes with medications like Zepbound

This guide explains those side effects in clear, simple language

With a surgery time ranging from 1 to 4 hours and a recovery period of 3 to 5 days, liposuction offers efficient results without lengthy hospital stays

The impact of semaglutide on musculoskeletal pain: A focus on cervical discomfort

Gclc f/f mice were generated as described 30 and crossed with the Rosa26-CreERT2 mouse strain (Jackson Labs, #008463) or Nrf2 f/f mouse strain (Jackson Labs, #025433)